Table 2 Outcome results
From: The impact of IgM deposits on the outcome of Nephrotic syndrome in children
IgM+ (n = 18) | IgM- (n = 27) | p value | |
|---|---|---|---|
Duration of follow-up, yearsc | 4.52 (0.85–13.14) | 3.55 (0.17–12.67) | 0.194 |
Age at last follow-up, yearsc | 12.86 (2.35–26.22) | 9.67 (1.87–24.06) | 0.438 |
Clinical data at follow-up, n (%) | |||
Hematuria | 6/18 (33.3) | 9/27 (33.3) | 1 |
Hypertension | 13/18 (72.2) | 14/27 (51.9) | 0.222 |
Decreased GFR | 4/18 (22.2) | 2/27 (7.4) | 0.199 |
Outcome, n (%) | |||
Remission | 11/18 (61.1) | 13/27 (48.1) | 0.543 |
Active disease, normal kidney function | 3/18 (16.7) | 12/27 (44.4) | 0.063 |
Active disease, impaired kidney function | 2/18 (11.1) | 1/27 (3.7) | 0.555 |
Renal replacement therapy | 2/18 (11.1) | 1/27 (3.7) | 0.555 |